Tag: Prescription Drugs
Women With MS Less Likely Than Men to Receive Disease-Modifying Therapies
Proportion of treated women began to decline 18 months before childbirth, reaching 27.9 percent at the estimated time of conception
Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease
Effectiveness seen for RSV lower respiratory tract disease, hospitalized RSV lower respiratory tract disease, PCR-confirmed RSV
Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
However, safer antiseizure medications are gaining favor
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010
Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased
Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
AOMs linked to significant weight regain at eight weeks after drug discontinuation compared with control group
Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
Both guselkumab regimens superior to placebo
More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis
Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
